
Sign up to save your podcasts
Or


At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
At least 5 agents that target the peroxisome proliferator-activated receptor (PPAR) are in clinical studies in primary biliary cholangitis (PBC). Are you aware of the latest data? Credit available for this activity expires: 2/21/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

135 Listeners

694 Listeners

496 Listeners

170 Listeners

101 Listeners

888 Listeners

13 Listeners

17 Listeners

290 Listeners

262 Listeners

3,333 Listeners

1,154 Listeners

195 Listeners

90 Listeners

515 Listeners

364 Listeners

171 Listeners

61 Listeners

8 Listeners

433 Listeners